Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: A review of 400 cases

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Barbetakis, Nikolaos ^a   Asteriou, Christos ^a   Papadopoulou, Fani ^a   Samanidis, Georgios ^a   Paliouras, Dimitrios ^a   Kleontas, Athanassios ^a   Lyriti, Konstantina ^a   Katsikas, Ioannis ^a   Tsilikas, Christodoulos ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TALC;

ARTICLE; HUMAN; MORTALITY; PALLIATIVE THERAPY; PLEURA EFFUSION; PLEURODESIS; RECURRENT DISEASE; THORACOSCOPY; VIDEORECORDING;

HUMANS; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; RECURRENCE; TALC; THORACOSCOPY; VIDEO RECORDING;

EID: 77950956221     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-27     Document Type: Article

References (15)

1. Lynch TJ. Management of pleural effusions. Chest 1993, 103:385-389.
2. American Thoracic Society Management of malignant pleural effusions. Am J Respir Crit Care Med 2000, 162:1987-2001. American Thoracic Society.
3. Cardillo G, Facciolo F, Carbone L, Regal M, Corzani F, Ricci A, Di Martino M, Martelli M. Long-term follow up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002, 21:302-306. 10.1016/S1010-7940(01)01130-7, 11825740.
4. Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small-bore versus large-bore chest tubes for treatment of malignant pleural effusions. Chest 2001, 120:19-25. 10.1378/chest.120.1.19, 11451810.
5. Barbetakis N, Antoniadis T, Tsilikas C. Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer. World Journal of Surgical Oncology 2004, 2:16. 10.1186/1477-7819-2-16, 420258, 15153245.
6. Marchi E, Vargas FS, Teixeira LR, Acencio MMP, Antonangelo L, Light RW. Intrapleural Low-Dose Silver Nitrate Elicits More Pleural Inflammation and Less Systemic Inflammation Than Low-Dose Talc. Chest 2005, 128:1798-1804. 10.1378/chest.128.3.1798, 16162789.
7. Musani AI. Treatment options for malignant pleural effusion. Current Opinion in Pulmonary Medicine 2009, 15:380-387. 10.1097/MCP.0b013e32832c6a8a, 19436206.
8. Chambers JS. Palliative treatment of neoplastic pleural effusions with intercostals intubation and talc instillation. West J Surg Obstet Gynecol 1958, 66:26-28.
9. Yim A, Chan ATC, Wai Lee T, Wan IYP, Ho JKS. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996, 62:1655-1658. 10.1016/S0003-4975(96)00808-9, 8957368.
10. Bernard A, de Dompsure RB, Hagry A, Favre JP. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002, 74:213-217. 10.1016/S0003-4975(02)03599-3, 12118761.
11. Schulze M, Boehle AS, Kurdow R, Dohrmann P, Henne-Bruns D. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001, 71:1809-1812. 10.1016/S0003-4975(01)02586-3, 11426752.
12. Sahn SA, Good JT. Pleural fluid pH in malignant effusion: diagnostic, prognostic and therapeutic implications. Ann Intern Med 1988, 108:345-347.
13. Rodriguez-Panadero F, Lopez-Mejias J. Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Chest 1989, 95:320-324. 10.1378/chest.95.2.320, 2914482.
14. Furedi A, Keekes L, Gether P, Kiss B. Video-assisted thoracoscopic talc pleurodesis for malignant pleural effusions. Acta Chir Hung 1999, 38:155-157.
15. Milanez de Campos R, Vargas FS, de Campos Werebe E. Thoracoscopy talc poudrage. A 15-year experience. Chest 2001, 119:801-806. 10.1378/chest.119.3.801, 11243960.